Armata Pharmaceuticals Statistics
Total Valuation
ARMP has a market cap or net worth of $218.99 million. The enterprise value is $381.91 million.
Important Dates
The last earnings date was Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ARMP has 36.41 million shares outstanding. The number of shares has increased by 0.16% in one year.
| Current Share Class | 36.41M |
| Shares Outstanding | 36.41M |
| Shares Change (YoY) | +0.16% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 0.76% |
| Owned by Institutions (%) | 2.10% |
| Float | 11.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 44.33 |
| Forward PS | 286.26 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 75.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.12
| Current Ratio | 0.12 |
| Quick Ratio | 0.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.22 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -22.20% |
| Return on Invested Capital (ROIC) | -24.32% |
| Return on Capital Employed (ROCE) | 66.13% |
| Weighted Average Cost of Capital (WACC) | 9.31% |
| Revenue Per Employee | $84,233 |
| Profits Per Employee | -$781,683 |
| Employee Count | 60 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +169.64% in the last 52 weeks. The beta is 1.31, so ARMP's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | +169.64% |
| 50-Day Moving Average | 6.38 |
| 200-Day Moving Average | 3.53 |
| Relative Strength Index (RSI) | 46.47 |
| Average Volume (20 Days) | 49,305 |
Short Selling Information
The latest short interest is 144,352, so 0.40% of the outstanding shares have been sold short.
| Short Interest | 144,352 |
| Short Previous Month | 131,252 |
| Short % of Shares Out | 0.40% |
| Short % of Float | 1.31% |
| Short Ratio (days to cover) | 3.36 |
Income Statement
In the last 12 months, ARMP had revenue of $5.05 million and -$46.90 million in losses. Loss per share was -$2.22.
| Revenue | 5.05M |
| Gross Profit | -21.04M |
| Operating Income | -33.35M |
| Pretax Income | -46.90M |
| Net Income | -46.90M |
| EBITDA | -31.86M |
| EBIT | -33.35M |
| Loss Per Share | -$2.22 |
Full Income StatementBalance Sheet
The company has $14.76 million in cash and $177.68 million in debt, with a net cash position of -$162.93 million or -$4.48 per share.
| Cash & Cash Equivalents | 14.76M |
| Total Debt | 177.68M |
| Net Cash | -162.93M |
| Net Cash Per Share | -$4.48 |
| Equity (Book Value) | -95.59M |
| Book Value Per Share | -2.64 |
| Working Capital | -123.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$27.02 million and capital expenditures -$413,000, giving a free cash flow of -$27.43 million.
| Operating Cash Flow | -27.02M |
| Capital Expenditures | -413,000 |
| Free Cash Flow | -27.43M |
| FCF Per Share | -$0.75 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -659.87% |
| Pretax Margin | -928.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ARMP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.16% |
| Shareholder Yield | -0.16% |
| Earnings Yield | -21.42% |
| FCF Yield | -12.53% |
Analyst Forecast
The average price target for ARMP is $12.00, which is 99.50% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 99.50% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ARMP has an Altman Z-Score of -8.47 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.47 |
| Piotroski F-Score | 3 |
